Agenda

7:30 a.m.

Registration and Breakfast

8:15 a.m.

Welcome
James A. Hoxie, M.D.
Director, Penn Center for AIDS Research

Arthur H. Rubenstein, MBBCh
Dean, University of Pennsylvania School of Medicine

8:30 a.m.

Session Chair, Philip R. Johnson, M.D.
Chief Scientific Officer, Children's Hospital of Philadelphia

8:35 a.m.

Gary J. Nabel, M.D., Ph.D.
Director, Vaccine Research Center, NIH
The Critical Path to an AIDS Vaccine

8:55 a.m.

Barton F. Haynes, M.D.
Professor of Medicine and Immunology
Director, Vaccine Institute, Duke University
Research Plans for the Center for HIV/AIDS Vaccine Immunology (CHAVI)

9:20 a.m.

Session Chair, Mr. J. Edward Murray
Vice Chair, Community Advisory Board, Penn Center for AIDS Research

Ms. Julie Furj, M.S.W.
Coordinator, Community Advisory Board, Penn Center for AIDS Research
U.S. Urban Epidemic and "The Community"

9:35 a.m.

Mr. Steven F. Wakefield
Director of Community Education, HIV Vaccine Trials Network
Fred Hutchinson Cancer Research Center
46% is Not Acceptable: How Did We Get Here?

10:00 a.m.

Break

10:15 a.m.

Session Chair: Harvey Friedman, M.D.
Director, Penn CFAR International Core
Chief, Division of Infectious Disease, University of Pennsylvania
The PENN-Botswana Program, Combining Patient Care and Clinical Research

10:25 a.m.

Peter Kilmarx, M.D.
Director, BOTUSA
Program Officer, CDC, PEPFAR
The Epidemiology of HIV/AIDS and Related Conditions in Botswana , and the Role of the U.S. President's Emergency Plan for AIDS Relief

10:50 a.m.

Mark Kline, M.D.
Director, Baylor International Pediatric AIDS Initiative
Director, AIDS International Training/Research Program
Director, CDC Global AIDS Technical Assistance Project
Expanding Access of Children to HIV/AIDS Care and Treatment: The Botswana-Baylor Children's Center of Excellence Model

11:15 a.m.

Richard Marlink, M.D.
Professor of Immunology and Infectious Diseases
Harvard School of Public Health
Botswana-Harvard Partnership: Principals of Collaboration. Guests, Partners, and Needs

11:40 a.m.

Tendani Gaolathe, M.D.
Co-Director, Infectious Disease Care Clinic
Princess Marina Hospital, Gaborone, Botswana
Managing Anti-retroviral Treatment Failure - IDCC Experience

12:00 p.m.

Session Chair, James A. Hoxie, M.D.
Director, Penn Center for AIDS Research

12:05 p.m.

Gerald Friedland, M.D.
Director, Yale AIDS Care Program
Summary of the June 2005 Symposium "Confronting TB/HIV Co-infection"

12:15 p.m.

Richard Chaisson, M.D.
Director, Johns Hopkins Center for Tuberculosis Research
Controlling HIV-related TB

12:40 p.m.

Lunch

1:35 p.m.

Session Chair, Robert Doms, M.D., Ph.D.
Director, Penn CFAR Pathogenesis Program
Chair, Department of Microbiology, University of Pennsylvania

1:40 p.m.

Michael Malim, D.Phil.
Professor and Head, Department of Infectious Diseases
Guy's, King's & St. Thomas' School of Medicine , King's College London
Resistance to HIV Infection: the Vif-APOBEC Interaction

2:05 p.m.

Frederic Bushman, Ph.D.
Professor of Microbiology, University of Pennsylvania
HIV DNA Integration

2:30 p.m.

Wesley Sundquist, Ph.D.
Professor of Biochemistry, Department of Molecular Biology, University of Utah
The Biochemistry of HIV Budding

2:55 p.m.

Peter Kwong, Ph.D.
Chief of the Structural Biology Section, Vaccine Research Center , NIH
The HIV Envelope: Recent Advances in Structural Understanding

3:20 p.m.

Break

3:30 p.m.

Session Chair, Francisco Gonzalez-Scarano, M.D.
Co-Director, Penn CFAR; Professor and Chair of Neurology
University of Pennsylvania

3:35 p.m.

Louis Picker, M.D.
Associate Director, Vaccine and Gene Therapy Institute
Oregon Health and Science University
Immunopathogenesis of SIV Infection

4:00 p.m.

David Watkins, Ph.D.
Professor of Pathology and Laboratory Medicine,
University of Wisconsin-Madison Medical School
Cellular Immune Responses in Elite Controllers of AIDS Virus Replication: Implications for Vaccine Development

4:25 p.m.

Carl June, M.D.
Director, Penn CFAR Immunology Core
Professor of Pathology and Laboratory Medicine, University of Pennsylvania
Lentiviral Gene Transfer Therapy for HIV/AIDS

4:50 p.m.

Closing Remarks: James A. Hoxie, M.D.
Director, Penn Center for AIDS Research